Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-021921
Filing Date
2026-03-02
Accepted
2026-03-02 08:00:10
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm267613-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm267613-1_4seq1.xml 4 4084
  Complete submission text file 0001104659-26-021921.txt   5824
Mailing Address 6 STONEGATE RD PONTOLA VALLEY CA 94028
Business Address
HERON ELAINE J (Reporting) CIK: 0001235471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 26703528

Mailing Address 353 W. LANCASTER AVENUE SUITE 200 WAYNE PA 19087
Business Address 353 W. LANCASTER AVENUE SUITE 200 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)